ScoreWhy is Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 11.84% and Operating profit at 6.18% over the last 5 years
2
Flat results in Sep 25
- ROCE(HY) Lowest at 7.32%
- DEBT-EQUITY RATIO (HY) Highest at -60.2 %
- RAW MATERIAL COST(Y) Grown by 5.84% (YoY)
3
Underperformed the market in the last 1 year
- The stock has generated a return of 13.20% in the last 1 year, much lower than market (China Shanghai Composite) returns of 25.05%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.
14.04%
0.32
35.07%
China Shanghai Composite
24.7%
1.93
12.95%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.84%
EBIT Growth (5y)
6.18%
EBIT to Interest (avg)
27.24
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.59
Tax Ratio
12.77%
Dividend Payout Ratio
26.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.52%
ROE (avg)
9.45%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
1.87
EV to EBIT
19.27
EV to EBITDA
14.64
EV to Capital Employed
3.19
EV to Sales
1.95
PEG Ratio
6.88
Dividend Yield
0.71%
ROCE (Latest)
16.56%
ROE (Latest)
7.24%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET SALES(9M)
At CNY 838.64 MM has Grown at 17.39%
CASH AND EQV(HY)
Highest at CNY 2,331.4 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 2.12 times
PRE-TAX PROFIT(Q)
Highest at CNY 36.7 MM
-5What is not working for the Company
ROCE(HY)
Lowest at 7.32%
DEBT-EQUITY RATIO
(HY)
Highest at -60.2 %
RAW MATERIAL COST(Y)
Grown by 5.84% (YoY
Here's what is working for Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.
Net Sales
At CNY 838.64 MM has Grown at 17.39%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 36.7 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Cash and Eqv
Highest at CNY 2,331.4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 2.12 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.
Debt-Equity Ratio
Highest at -60.2 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 5.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
